Blog Layout

Semaglutide Weight Loss in Lancaster, California

August 7, 2023

Weight Loss in Lancaster, California

Familyfirst Urgent Care offers solutions to reduce the obesity impacting all generations today. 


Obesity is a multifaceted chronic disease that is increasingly affecting children, adolescents, and adults. In the United States, the prevalence of obesity has doubled among children and tripled among adolescents since 1980. Currently, approximately 19.7% of children aged 2 to 19 are classified as obese, while the figure rises to over 41% among adults. The ramifications of this trend are profound, with health care professionals noting a surge in the early onset of type 2 diabetes, cardiovascular diseases, and mental health issues such as depression and social isolation among the younger population.


The urgency of addressing obesity in childhood stems from the heightened risk of these conditions persisting into adulthood, with each advancing year of age compounding the likelihood. Consequently, this elevates the individual’s risk for chronic conditions like diabetes, hypertension, and heart disease. 


Prevention strategies are therefore critical to mitigate these risks and promote long-term health and well-being.


Our Familyfirst Urgent Care weight loss clinics can help you reach a healthy weight.





Peptides are short chains of amino acids, the building blocks of proteins. In the human body, they serve various functions. Peptides can act as signaling molecules, transmitting messages between cells and regulating biological processes. They are involved in metabolism, immune response, and tissue repair, among other vital functions. Some peptides are FDA approved for the treatment of certain diseases. Other peptides used clinically are prepared by an FDA registered cGMP sterile laboratory complying with all state and federal laws. Peptides can be administered in various presentations, including but not limited to oral, intravenous, subcutaneous, intramuscular and intranasal routes.


Prolonged shortages of popular new weight loss drugs including Zepbound and Wegovy are causing frustrations for patients, pharmacists and medical providers, and there’s no immediate relief in sight.  Compounding pharmacies are authorized to produce equivalents of FDA-approved medications during drug shortages. This practice is supported by the FDA, particularly when the active ingredients are included on the agency’s drug shortage list. Semaglutide and tirzepatide, the active components in the widely-used weight loss medications Wegovy and Zepbound, have been subject to such shortages. The FDA’s endorsement of compounding pharmacies’ efforts helps ensure continued access to these important drugs when supply is limited.




SEMAGLUTIDE: ONCE A WEEK INJECTION

GLP-1 receptor agonists, particularly Semaglutide, are heralded as a revolutionary breakthrough in the fight against obesity, marking a new era in hormonal treatment strategies. Esteemed experts in the field have lauded these medications as a “game-changer” in obesity medicine, underscoring their significant impact on health management.


Semaglutide, a prominent member of the GLP-1 receptor agonist class, has received FDA approval for its efficacy in managing type 2 diabetes and facilitating weight loss in adults seeking to reduce their body weight. This endorsement reflects the growing confidence in GLP-1 based therapies as a transformative approach to weight management and diabetes care.


It’s important to note that while GLP-1 medications like Semaglutide offer substantial benefits, they are most effective when combined with lifestyle changes such as diet and exercise4Moreover, the medical community is actively researching and developing new GLP-1 drugs that promise to extend health benefits beyond weight loss, potentially improving liver and heart function while minimizing side effects.





Semaglutide Injections - Here in Lancaster, California.

In the United States, nearly 70% of adults are grappling with obesity or overweight conditions, which are significant contributors to some of the leading causes of mortality, including heart disease. One potential avenue for weight management is the prescription medication Ozempic, known generically as semaglutide, a GLP-1 analog. Suitable candidates may receive this medication as a once-weekly injection that emulates the body’s natural hormones, promoting a sense of satiety sooner and sustaining it for a longer duration.


Despite earnest efforts—such as calorie restriction, increased physical activity, and various dieting approaches—many find sustained weight loss to be an elusive goal. Often, initial success is followed by a relapse to the starting point.


Nonetheless, even a modest weight reduction of 5% to 10% through diet and exercise has been shown to significantly decrease the risk of cardiovascular diseases in adults with obesity or overweight. However, achieving this can be challenging for some.


At Familyfirst Urgent Care, , Semaglutide Injections are administered with the utmost care by our premier medical experts across all locations. During a complimentary consultation, our skilled team will evaluate your eligibility for our managed weight loss program that includes Semaglutide Injections, ensuring a personalized approach to your health journey.




Some of the health benefits associated with Semaglutide and/or weightloss include the following:

  • Lower blood sugar without any increase in hypoglycemia
  • Reduced body weight, lipids, blood pressure, inflammatory markers, and oxidative stress
  • Suppressed appetite
  • Enhanced insulin synthesis and secretion
  • Reduced glucagon levels in fasting and after eating
  • A promoted sensation of fullness in the brain
  • Slowed gastric emptying in the intestines to help you feel fuller for longer
  • Weight loss
  • More significant improvement in cardiovascular risk factors associated with obesity



What is included in our packages:


  • Prescription for GLP-1 OR GIP/GLP-1 medication (Semaglutide or Tirzepatide).
  • Blood work review as needed.
  • Insulin syringes provided for at-home injections.
  • Once a month check in appointment to monitor weight and BMI for results tracking.
  • Individual counseling & support with our nurse practitioner throughout your membership every 4 weeks as needed.


Visit Family First Family Medical Practice by clicking on the following link www.familyfirstmedgroup.com


To learn more about our providers, click on the following link below:


https://www.familyfirstmedgroup.com/providers


We are currently open to new patients.


We take same day walkings or schedule three days in advance by calling 661-341-3800.


urgent care center sign from Family First Family Medical Practice in Lancaster, CA
February 24, 2025
Discover tips for your visit to urgent care in Lancaster, CA, ensuring a smooth trip to Family First Family Medical Practice. Click here to learn more!
August 27, 2024
Weight Loss
August 27, 2024
Medical Weight Loss Specialists in Lancaster, California. Local weight loss in Lancaster, Ca by calling 341-3800.
August 20, 2024
Walk-in Clinic Urgent Care in Lancaster, CA 42135 10th St W #102, Lancaster, CA 93534 Phone 661-341-3800. No accepting walk-in urgent care patients. Providers specialized in walk-in urgent care. same day.
August 20, 2024
Walk-in Clinic Urgent Care 42135 10th St W #102, Lancaster, CA 93534 Phone 661-341-3800. No accepting walk-in urgent care patients. Providers specialized in walk-in urgent care. same day.
August 7, 2024
Familyfirst Urgent Care and Semaglutide Weight Loss Clinic in Lancaster, California have extensive experience in proven weight loss strategies. Call us at 341-3800.
July 22, 2024
Familyfirst Urgent Care has added Weight Loss with Semaglutide for Lancaster and Palmdale California. GLP-1 661-341-3800
May 3, 2024
AV's Best Family Medicine Physician 2024 winner Dr. Qanwar Sidhu works at Familyfirst Family Medical Practice. Call to schedule an appointment at 661-341-3800.
May 2, 2024
Dr. Susan Nasser wins AV's Best 2024 Pediatrician in Lancaster, CA. Call to schedule at 341-3800.
April 25, 2024
NEXPLANON (Etonogestrel Implant) 68 mg Radiopaque is a prescription birth control for the prevention of pregnancy in women. Call us at Familyfirst to schedule an implant or removal at 661-341-3800
More Posts
Share by: